Complete Filing Data
Uber Technologies, Inc reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $27.92 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Uber Technologies, Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $10.05B | $9.86B | $1.89B | -$9.14B | -$496.0M | -$6.77B | -$8.51B | $997.0M | -$4.03B |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $81.0M | -$95.0M | $17.0M | $81.0M | $57.0M | -$350.0M | -$3.0M | -$225.0M | -$4.0M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $9.0M | -$1.0M | $5.0M | $0.00 | -$46.0M | $2.0M | $4.0M | $40.0M | $0.00 |
| Operating Income Loss | $5.57B | $2.80B | $1.11B | -$1.83B | -$3.83B | -$4.86B | -$8.60B | -$3.03B | -$4.08B |
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | $10.15B | $9.91B | $2.22B | -$9.10B | -$484.0M | -$6.74B | -$8.49B | $997.0M | -$4.03B |
| Selling And Marketing Expense | $4.90B | $4.34B | $4.36B | $4.76B | $4.79B | $3.58B | $4.63B | $3.15B | $2.52B |
| Revenues | $52.02B | $43.98B | $37.28B | $31.88B | $17.46B | $11.14B | $13.00B | $10.43B | $7.93B |
| Research And Development Expense | $3.40B | $3.11B | $3.16B | $2.80B | $2.05B | $2.21B | $4.84B | $1.51B | $1.20B |
| Income Tax Expense Benefit | -$4.35B | -$5.76B | $213.0M | -$181.0M | -$492.0M | -$192.0M | $45.0M | $283.0M | -$542.0M |
| Income Loss From Equity Method Investments | -$53.0M | -$38.0M | $48.0M | $107.0M | -$37.0M | -$34.0M | -$34.0M | -$42.0M | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $5.80B | $4.13B | $2.32B | -$9.43B | -$1.03B | -$6.95B | -$8.43B | $1.31B | -$4.58B |
| General And Administrative Expense | $3.24B | $3.64B | $2.68B | $3.14B | $2.32B | $2.67B | $3.30B | $2.08B | $2.26B |
| Net Income Loss Attributable To Noncontrolling Interest | $40.0M | -$11.0M | $269.0M | $3.0M | -$74.0M | -$20.0M | -$6.0M | -$10.0M | $0.00 |
| Other Comprehensive Income Loss Net Of Tax | $85.0M | -$96.0M | $22.0M | $81.0M | $11.0M | -$348.0M | $1.0M | -$185.0M | -$4.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $10.18B | $9.75B | $2.18B | -$9.06B | -$559.0M | -$7.14B | -$8.51B | $802.0M | -$4.04B |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $40.0M | -$11.0M | $269.0M | $3.0M | -$74.0M | -$20.0M | -$6.0M | -$10.0M | $0.00 |
| Comprehensive Income Net Of Tax | $10.14B | $9.76B | $1.91B | -$9.06B | -$485.0M | -$7.12B | -$8.51B | $812.0M | -$4.04B |
| Nonoperating Income Expense | $1.85B | $1.84B | -$7.03B | $3.29B | -$1.63B | $722.0M | $4.99B | -$16.0M | |
| Interest Expense | $633.0M | $565.0M | $483.0M | $458.0M | $559.0M | $648.0M | $479.0M | ||
| Income Taxes Paid Net | $345.0M | $324.0M | $234.0M | $175.0M | $87.0M | $82.0M | $133.0M | $289.0M | $153.0M |
| Deferred Income Tax Expense Benefit | -$4.78B | -$6.03B | $26.0M | -$441.0M | -$692.0M | -$266.0M | -$88.0M | $35.0M | -$762.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $6.63B | $1.36B | $1.78B | $2.61B | $1.02B | -$654.0M | $221.0M | $394.0M | -$157.0M | -$1.21B | -$2.60B | -$5.93B | -$2.42B | $1.14B | -$108.0M | -$1.09B | -$1.78B | -$2.94B | -$1.16B | -$5.24B | -$1.01B | -$986.0M | -$878.0M | $3.75B |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $0.00 | $52.0M | $31.0M | $27.0M | -$41.0M | -$8.0M | -$37.0M | $157.0M | -$155.0M | $295.0M | -$200.0M | $19.0M | $24.0M | $21.0M | $33.0M | $137.0M | -$257.0M | -$148.0M | -$14.0M | $71.0M | -$54.0M | -$154.0M | -$58.0M | -$7.0M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $5.0M | -$2.0M | $1.0M | $28.0M | -$1.0M | -$8.0M | $0.00 | -$2.0M | $0.00 | $0.00 | $0.00 | $0.00 | $463.0M | $6.0M | $1.16B | $62.0M | $8.0M | -$60.0M | -$4.0M | $8.0M | -$4.0M | $3.0M | $39.0M | $0.00 |
| Operating Income Loss | $1.11B | $1.45B | $1.23B | $1.06B | $796.0M | $172.0M | $394.0M | $326.0M | -$262.0M | -$495.0M | -$713.0M | -$482.0M | -$572.0M | -$1.19B | -$1.52B | -$1.12B | -$1.61B | -$1.26B | -$1.11B | -$5.49B | -$1.03B | -$763.0M | -$739.0M | -$478.0M |
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | $6.67B | $1.37B | $1.79B | $2.62B | $1.03B | -$643.0M | $232.0M | $405.0M | -$146.0M | -$1.20B | -$2.59B | -$5.92B | -$2.42B | $1.14B | -$108.0M | -$1.09B | -$1.77B | -$2.93B | -$1.15B | -$5.24B | -$1.01B | -$986.0M | -$878.0M | $3.75B |
| Selling And Marketing Expense | $1.28B | $1.21B | $1.06B | $1.10B | $1.12B | $917.0M | $941.0M | $1.22B | $1.26B | $1.15B | $1.22B | $1.26B | $1.17B | $1.26B | $1.10B | $924.0M | $736.0M | $885.0M | $1.11B | $1.22B | $1.04B | $785.0M | $715.0M | $677.0M |
| Revenues | $13.47B | $12.65B | $11.53B | $11.19B | $10.70B | $10.13B | $9.29B | $9.23B | $8.82B | $8.34B | $8.07B | $6.85B | $4.85B | $3.93B | $2.90B | $2.81B | $1.91B | $3.25B | $3.81B | $3.17B | $3.10B | $2.94B | $2.77B | $2.58B |
| Research And Development Expense | $862.0M | $840.0M | $815.0M | $774.0M | $760.0M | $790.0M | $797.0M | $808.0M | $775.0M | $760.0M | $704.0M | $587.0M | $493.0M | $488.0M | $515.0M | $493.0M | $584.0M | $645.0M | $755.0M | $3.06B | $409.0M | $434.0M | $365.0M | $340.0M |
| Income Tax Expense Benefit | -$4.05B | $142.0M | -$402.0M | $158.0M | $57.0M | $29.0M | -$40.0M | $65.0M | $55.0M | $58.0M | $77.0M | -$232.0M | -$101.0M | -$479.0M | $185.0M | $23.0M | $4.0M | -$242.0M | $3.0M | -$2.0M | $19.0M | $1.0M | $28.0M | $576.0M |
| Income Loss From Equity Method Investments | -$14.0M | -$12.0M | -$13.0M | -$12.0M | -$12.0M | -$4.0M | $3.0M | $4.0M | $36.0M | $30.0M | $17.0M | $18.0M | -$13.0M | -$7.0M | -$8.0M | -$8.0M | -$7.0M | -$12.0M | -$9.0M | -$10.0M | -$6.0M | -$15.0M | -$14.0M | -$3.0M |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $2.62B | $1.50B | $1.39B | $2.77B | $1.08B | -$630.0M | $176.0M | $455.0M | -$138.0M | -$1.18B | -$2.56B | -$6.17B | -$2.53B | $640.0M | $71.0M | -$1.08B | -$1.76B | -$3.18B | -$1.15B | -$5.24B | -$991.0M | -$978.0M | -$836.0M | $4.33B |
| General And Administrative Expense | $1.18B | $669.0M | $657.0M | $630.0M | $686.0M | $1.21B | $646.0M | $491.0M | $942.0M | $908.0M | $851.0M | $632.0M | $625.0M | $616.0M | $464.0M | $711.0M | $565.0M | $859.0M | $591.0M | $1.64B | $423.0M | $460.0M | $638.0M | $429.0M |
| Net Income Loss Attributable To Noncontrolling Interest | $26.0M | -$5.0M | -$2.0M | -$13.0M | -$7.0M | -$9.0M | -$2.0M | $0.00 | $0.00 | $2.0M | -$15.0M | $12.0M | -$15.0M | -$32.0M | -$14.0M | -$19.0M | $3.0M | -$10.0M | $3.0M | -$10.0M | -$4.0M | -$8.0M | ||
| Other Comprehensive Income Loss Net Of Tax | $5.0M | $50.0M | $32.0M | $55.0M | -$42.0M | -$16.0M | -$37.0M | $155.0M | -$155.0M | $295.0M | -$200.0M | $19.0M | $487.0M | $27.0M | $1.19B | $199.0M | -$249.0M | -$208.0M | -$18.0M | $79.0M | -$58.0M | -$151.0M | -$19.0M | -$7.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $6.66B | $1.40B | $1.81B | $2.65B | $966.0M | -$679.0M | $182.0M | $549.0M | -$312.0M | -$909.0M | -$2.82B | -$5.90B | -$1.95B | $1.14B | $1.07B | -$909.0M | -$2.02B | -$3.15B | -$1.18B | -$5.17B | -$1.07B | -$1.15B | -$897.0M | $3.74B |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $26.0M | -$5.0M | -$2.0M | -$13.0M | -$7.0M | -$9.0M | -$2.0M | $0.00 | $0.00 | $2.0M | -$15.0M | $12.0M | -$15.0M | -$32.0M | -$14.0M | -$19.0M | $3.0M | -$10.0M | $3.0M | -$10.0M | -$4.0M | -$8.0M | $0.00 | $0.00 |
| Comprehensive Income Net Of Tax | $6.63B | $1.41B | $1.81B | $2.67B | $973.0M | -$670.0M | $184.0M | $549.0M | -$312.0M | -$911.0M | -$2.80B | -$5.91B | -$1.94B | $1.17B | $1.08B | -$890.0M | -$2.02B | -$3.14B | -$1.18B | -$5.16B | -$1.07B | -$1.14B | -$897.0M | $3.74B |
| Nonoperating Income Expense | $1.62B | $162.0M | $262.0M | $1.85B | $420.0M | -$678.0M | -$52.0M | $273.0M | $292.0M | -$535.0M | -$1.70B | -$5.56B | -$1.83B | $1.94B | $1.71B | $151.0M | -$44.0M | -$1.80B | $49.0M | $398.0M | $260.0M | -$54.0M | $63.0M | $4.94B |
| Interest Expense | $124.0M | $166.0M | $144.0M | $168.0M | $146.0M | $139.0M | $129.0M | $123.0M | $115.0M | $115.0M | $112.0M | $110.0M | $118.0M | $90.0M | $151.0M | $217.0M | $161.0M | $160.0M | $132.0M | |||||
| Income Taxes Paid Net | $55.0M | $71.0M | $22.0M | $41.0M | $22.0M | $36.0M | $34.0M | $53.0M | ||||||||||||||||
| Deferred Income Tax Expense Benefit | -$412.0M | -$16.0M | $10.0M | -$281.0M | $120.0M | -$273.0M | $4.0M | $486.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $27.04B | $21.56B | $11.25B | $7.34B | $14.46B | $12.27B | $14.19B | -$7.39B | -$8.56B | -$4.60B |
| Restricted Cash And Cash Equivalents Noncurrent | $1.91B | $2.17B | $1.52B | $1.79B | $2.88B | $1.49B | $1.10B | $1.74B | $1.29B | |
| Restricted Cash And Cash Equivalents At Carrying Value | $631.0M | $545.0M | $805.0M | $680.0M | $631.0M | $250.0M | $99.0M | $67.0M | $142.0M | |
| Cash And Cash Equivalents At Carrying Value | $7.11B | $5.89B | $4.68B | $4.21B | $4.30B | $5.65B | $10.87B | $6.41B | $4.39B | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $9.65B | $8.61B | $7.00B | $6.68B | $7.81B | $7.39B | $12.07B | $8.21B | $5.83B | |
| Goodwill | $8.93B | $8.07B | $8.15B | $8.26B | $8.42B | $6.11B | $167.0M | $153.0M | $39.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.04B | $1.61B | $327.0M | -$1.13B | $65.0M | -$4.33B | $3.82B | $2.29B | -$868.0M | |
| Finance Lease Principal Payments | $157.0M | $172.0M | $171.0M | $184.0M | $226.0M | $224.0M | $138.0M | |||
| Retained Earnings Accumulated Deficit | -$10.63B | -$20.73B | -$30.59B | -$32.77B | -$23.63B | -$23.13B | -$16.36B | -$7.87B | ||
| Redeemable Noncontrolling Interest Equity Carrying Amount | $165.0M | $93.0M | $654.0M | $430.0M | $204.0M | $787.0M | $311.0M | $0.00 | ||
| Prepaid Expense And Other Assets Current | $1.90B | $1.39B | $1.68B | $1.48B | $1.45B | $1.22B | $1.30B | $860.0M | ||
| Other Liabilities Noncurrent | $412.0M | $449.0M | $645.0M | $786.0M | $935.0M | $1.31B | $1.41B | $4.07B | ||
| Other Assets Noncurrent | $3.62B | $2.57B | $1.59B | $518.0M | $397.0M | $124.0M | $88.0M | $51.0M | ||
| Long Term Debt Noncurrent | $10.52B | $8.35B | $9.46B | $9.27B | $9.28B | $7.56B | $5.71B | $6.87B | ||
| Liabilities Current | $12.32B | $11.48B | $9.45B | $8.85B | $9.02B | $6.87B | $5.64B | $4.26B | ||
| Liabilities And Stockholders Equity | $61.80B | $51.24B | $38.70B | $32.11B | $38.77B | $33.25B | $31.76B | $23.99B | ||
| Liabilities | $33.72B | $28.77B | $26.02B | $23.61B | $23.43B | $19.50B | $16.58B | $17.20B | ||
| Intangible Assets Net Excluding Goodwill | $1.05B | $1.13B | $1.43B | $1.87B | $2.41B | $1.56B | $71.0M | $82.0M | ||
| Equity Method Investments | $287.0M | $302.0M | $353.0M | $870.0M | $800.0M | $1.08B | $1.36B | $1.31B | ||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Assets Current | $13.99B | $12.25B | $11.30B | $9.25B | $8.82B | $9.88B | $13.93B | $8.66B | ||
| Assets | $61.80B | $51.24B | $38.70B | $32.11B | $38.77B | $33.25B | $31.76B | $23.99B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $28.13B | $22.60B | $21.98B | $14.78B | $12.35B | $11.06B | $9.36B | $8.66B | $7.51B | $6.25B | $6.66B | $8.92B | $13.93B | $14.18B | $13.60B | $8.94B | $9.55B | $11.34B | $15.06B | $15.92B | -$8.43B | -$6.54B | -$5.51B | -$4.73B | -$8.56B |
| Restricted Cash And Cash Equivalents Noncurrent | $2.57B | $2.04B | $2.22B | $1.92B | $2.61B | $2.16B | $1.58B | $2.56B | $1.85B | $3.18B | $2.94B | $2.87B | $2.89B | $1.69B | $1.52B | $1.39B | $1.22B | $1.17B | $1.96B | $1.81B | $1.80B | $1.54B | $1.52B | $1.43B | |
| Restricted Cash And Cash Equivalents At Carrying Value | $477.0M | $1.19B | $1.25B | $933.0M | $776.0M | $808.0M | $833.0M | $909.0M | $897.0M | $593.0M | $526.0M | $543.0M | $414.0M | $324.0M | $247.0M | $218.0M | $123.0M | $193.0M | $33.0M | $137.0M | $136.0M | $214.0M | $118.0M | $117.0M | |
| Cash And Cash Equivalents At Carrying Value | $8.43B | $6.44B | $5.13B | $6.15B | $4.50B | $5.02B | $4.45B | $5.00B | $4.05B | $4.87B | $4.40B | $4.18B | $6.48B | $4.44B | $4.84B | $6.15B | $6.75B | $8.17B | $12.65B | $11.74B | $5.75B | $4.76B | $5.65B | $4.72B | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.48B | $9.67B | $8.60B | $9.00B | $7.88B | $7.98B | $6.87B | $8.46B | $6.79B | $8.63B | $7.86B | $7.59B | $9.79B | $6.45B | $6.61B | $7.77B | $8.10B | $9.53B | $14.64B | $13.69B | $7.68B | $6.51B | $7.28B | $6.26B | |
| Goodwill | $8.92B | $8.91B | $8.07B | $8.09B | $8.08B | $8.09B | $8.14B | $8.15B | $8.19B | $8.30B | $8.36B | $8.44B | $6.45B | $6.45B | $6.35B | $2.99B | $2.52B | $2.57B | $167.0M | $167.0M | $153.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$10.0M | $980.0M | $116.0M | -$213.0M | -$1.13B | -$2.54B | -$561.0M | $444.0M | |||||||||||||||||
| Finance Lease Principal Payments | $47.0M | $42.0M | $40.0M | $62.0M | $47.0M | $60.0M | $41.0M | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$10.94B | -$17.59B | -$18.95B | -$27.62B | -$30.23B | -$31.25B | -$32.31B | -$32.53B | -$32.92B | -$33.36B | -$32.16B | -$29.56B | -$24.52B | -$22.09B | -$23.24B | -$22.16B | -$21.07B | -$19.30B | -$15.27B | -$14.10B | -$8.87B | ||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | $158.0M | $183.0M | $93.0M | $946.0M | $631.0M | $651.0M | $394.0M | $408.0M | $419.0M | $430.0M | $194.0M | $205.0M | $229.0M | $1.57B | $473.0M | $549.0M | $282.0M | $290.0M | $309.0M | -$14.0M | -$4.0M | ||||
| Prepaid Expense And Other Assets Current | $1.80B | $1.78B | $1.58B | $1.62B | $1.63B | $1.80B | $1.67B | $1.65B | $1.56B | $1.44B | $1.37B | $1.46B | $1.46B | $1.26B | $1.32B | $1.14B | $1.15B | $1.24B | $1.32B | $1.13B | $975.0M | ||||
| Other Liabilities Noncurrent | $430.0M | $467.0M | $408.0M | $638.0M | $734.0M | $784.0M | $871.0M | $822.0M | $798.0M | $762.0M | $659.0M | $679.0M | $1.13B | $1.24B | $1.74B | $1.48B | $1.45B | $1.50B | $1.43B | $1.49B | $3.59B | ||||
| Other Assets Noncurrent | $3.32B | $3.26B | $2.97B | $2.63B | $2.25B | $1.94B | $1.59B | $704.0M | $554.0M | $384.0M | $406.0M | $415.0M | $372.0M | $346.0M | $332.0M | $123.0M | $120.0M | $146.0M | $60.0M | $57.0M | $64.0M | ||||
| Long Term Debt Noncurrent | $10.62B | $9.58B | $8.35B | $10.99B | $9.45B | $9.46B | $9.25B | $9.26B | $9.26B | $9.27B | $9.27B | $9.27B | $9.28B | $7.80B | $7.80B | $6.67B | $6.69B | $5.70B | $5.71B | $4.53B | $6.94B | ||||
| Liabilities Current | $13.12B | $12.69B | $12.11B | $10.84B | $10.32B | $9.99B | $9.41B | $8.64B | $8.68B | $9.02B | $8.95B | $8.65B | $8.13B | $7.68B | $7.29B | $6.92B | $5.89B | $6.63B | $5.37B | $5.57B | $4.71B | ||||
| Liabilities And Stockholders Equity | $63.34B | $55.98B | $52.82B | $47.12B | $41.51B | $39.60B | $35.95B | $34.07B | $32.45B | $31.11B | $31.01B | $32.81B | $36.88B | $36.25B | $34.66B | $28.89B | $28.24B | $30.09B | $32.29B | $30.98B | $24.39B | ||||
| Liabilities | $34.19B | $32.35B | $29.92B | $30.58B | $27.73B | $27.10B | $25.43B | $24.24B | $23.78B | $23.71B | $23.45B | $22.99B | $22.60B | $20.51B | $20.58B | $18.71B | $17.72B | $17.77B | $16.24B | $15.07B | $18.60B | ||||
| Intangible Assets Net Excluding Goodwill | $1.10B | $1.19B | $1.07B | $1.19B | $1.27B | $1.34B | $1.51B | $1.61B | $1.77B | $1.99B | $2.12B | $2.27B | $1.28B | $1.38B | $1.46B | $654.0M | $533.0M | $560.0M | $74.0M | $78.0M | $78.0M | ||||
| Equity Method Investments | $315.0M | $331.0M | $338.0M | $314.0M | $342.0M | $354.0M | $50.0M | $59.0M | $740.0M | $902.0M | $521.0M | $624.0M | $971.0M | $1.10B | $1.13B | $1.19B | $1.06B | $1.30B | $1.39B | $1.37B | $1.32B | ||||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Assets Current | $15.14B | $14.11B | $12.35B | $15.33B | $12.48B | $12.07B | $10.68B | $10.66B | $9.20B | $9.37B | $8.75B | $8.67B | $9.68B | $7.78B | $8.30B | $9.41B | $9.66B | $11.11B | $15.15B | $14.30B | $7.93B | ||||
| Assets | $63.34B | $55.98B | $52.82B | $47.12B | $41.51B | $39.60B | $35.95B | $34.07B | $32.45B | $31.11B | $31.01B | $32.81B | $36.88B | $36.25B | $34.66B | $28.89B | $28.24B | $30.09B | $32.29B | $30.98B | $24.39B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $31.34B | $26.65B | $22.46B | $19.66B | $9.35B | $5.15B | $6.06B | $4.79B | $4.16B |
| Depreciation Depletion And Amortization | $719.0M | $711.0M | $823.0M | $947.0M | $902.0M | $575.0M | $472.0M | $426.0M | $510.0M |
| Adjustments Related To Tax Withholding For Share Based Compensation | $52.0M | $49.0M | $18.0M | $17.0M | $28.0M | $17.0M | $1.57B | ||
| Share Based Compensation | $1.83B | $1.80B | $1.94B | $1.79B | $1.17B | $827.0M | $4.60B | $170.0M | $124.0M |
| Proceeds From Payments For Other Financing Activities | -$116.0M | $46.0M | -$203.0M | -$68.0M | $74.0M | $21.0M | -$34.0M | $23.0M | $2.0M |
| Payments To Acquire Property Plant And Equipment | $336.0M | $242.0M | $223.0M | $252.0M | $298.0M | $616.0M | $588.0M | $558.0M | $821.0M |
| Net Cash Provided By Used In Operating Activities | $10.10B | $7.14B | $3.59B | $642.0M | -$445.0M | -$2.75B | -$4.32B | -$1.54B | -$1.42B |
| Net Cash Provided By Used In Investing Activities | -$3.56B | -$3.18B | -$3.23B | -$1.64B | -$1.20B | -$2.87B | -$790.0M | -$695.0M | -$487.0M |
| Net Cash Provided By Used In Financing Activities | -$5.71B | -$2.09B | -$95.0M | $15.0M | $1.78B | $1.38B | $8.94B | $4.64B | $1.02B |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.03B | $694.0M | $1.46B | $196.0M | $236.0M | -$94.0M | $478.0M | $473.0M | $120.0M |
| Increase Decrease In Insurance Reserve | $2.66B | $2.82B | $2.23B | $730.0M | $516.0M | -$3.0M | $481.0M | $943.0M | $1.28B |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $967.0M | $330.0M | $80.0M | $498.0M | $1.07B | $83.0M | $960.0M | $738.0M | $1.27B |
| Increase Decrease In Accounts Receivable | $466.0M | $142.0M | $758.0M | $542.0M | $597.0M | -$142.0M | $407.0M | $279.0M | $442.0M |
| Increase Decrease In Accounts Payable | $126.0M | $86.0M | $64.0M | -$133.0M | $90.0M | -$133.0M | $95.0M | -$39.0M | -$79.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $215.0M | -$267.0M | $63.0M | -$148.0M | -$69.0M | -$92.0M | -$4.0M | -$119.0M | $22.0M |
| Increase Decrease In Operating Lease Right Of Use Assets | -$177.0M | -$196.0M | -$191.0M | -$193.0M | -$165.0M | -$341.0M | -$201.0M | $0.00 | $0.00 |
| Proceeds From Sale And Maturity Of Marketable Securities | $20.05B | $10.20B | $5.07B | $376.0M | $2.29B | $1.36B | $2.0M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $8.11B | $7.61B | $6.94B | $6.76B | $6.49B | $6.17B | $5.63B | $5.52B | $5.26B | $5.17B | $5.15B | $4.03B | $2.44B | $2.10B | $1.71B | $1.30B | $924.0M | $1.49B | $1.86B | $1.74B | $1.68B | $1.51B | $1.34B | $1.16B |
| Depreciation Depletion And Amortization | $188.0M | $175.0M | $171.0M | $179.0M | $173.0M | $190.0M | $205.0M | $208.0M | $207.0M | $227.0M | $243.0M | $254.0M | $218.0M | $226.0M | $212.0M | $138.0M | $129.0M | $128.0M | $102.0M | $123.0M | $146.0M | $131.0M | $98.0M | $88.0M |
| Adjustments Related To Tax Withholding For Share Based Compensation | $7.0M | $5.0M | $33.0M | $4.0M | $5.0M | $36.0M | $3.0M | $3.0M | $7.0M | $2.0M | $2.0M | $11.0M | $6.0M | $3.0M | $14.0M | $11.0M | $1.0M | $3.0M | $147.0M | $1.37B | ||||
| Share Based Compensation | $435.0M | $484.0M | $470.0M | $359.0M | $281.0M | $277.0M | $11.0M | $61.0M | ||||||||||||||||
| Proceeds From Payments For Other Financing Activities | -$30.0M | -$52.0M | -$51.0M | -$45.0M | $15.0M | -$3.0M | -$5.0M | -$64.0M | ||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $74.0M | $57.0M | $57.0M | $62.0M | $71.0M | $198.0M | $129.0M | $90.0M | ||||||||||||||||
| Net Cash Provided By Used In Operating Activities | $2.32B | $1.42B | $606.0M | $15.0M | -$611.0M | -$463.0M | -$722.0M | -$297.0M | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$542.0M | -$242.0M | -$399.0M | -$135.0M | -$250.0M | -$1.86B | $204.0M | -$375.0M | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$1.86B | -$100.0M | -$107.0M | -$113.0M | -$226.0M | -$63.0M | -$46.0M | $1.11B | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $497.0M | $322.0M | $119.0M | $20.0M | $67.0M | -$29.0M | $116.0M | $175.0M | ||||||||||||||||
| Increase Decrease In Insurance Reserve | $675.0M | $696.0M | $350.0M | $134.0M | -$27.0M | $77.0M | $161.0M | $260.0M | ||||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $430.0M | $587.0M | -$142.0M | -$72.0M | $556.0M | -$320.0M | $370.0M | $74.0M | ||||||||||||||||
| Increase Decrease In Accounts Receivable | $123.0M | $422.0M | -$168.0M | $26.0M | $35.0M | -$444.0M | $210.0M | $4.0M | ||||||||||||||||
| Increase Decrease In Accounts Payable | $6.0M | $46.0M | -$7.0M | $8.0M | -$3.0M | -$46.0M | $0.00 | -$66.0M | ||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $70.0M | -$94.0M | $16.0M | $20.0M | -$46.0M | -$156.0M | $3.0M | $2.0M | ||||||||||||||||
| Increase Decrease In Operating Lease Right Of Use Assets | -$43.0M | -$46.0M | -$52.0M | -$42.0M | -$38.0M | -$57.0M | -$41.0M | |||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $2.40B | $2.03B | $500.0M | $0.00 | $696.0M | $100.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 2.09B | 2.09B | 2.04B | 1.97B | 1.89B | 1.75B | 1.25B | 443.4M | 426.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 2.12B | 2.15B | 2.09B | 1.97B | 1.90B | 1.75B | 1.25B | 479.0M | 426.4M |
| Earnings Per Share Diluted | $4.73 | $4.56 | $0.87 | $-4.65 | $-0.29 | $-3.86 | $-6.81 | $0.00 | $-9.46 |
| Earnings Per Share Basic | $4.82 | $4.71 | $0.93 | $-4.64 | $-0.26 | $-3.86 | $-6.81 | $0.00 | $-9.46 |
| Common Stock Shares Outstanding | 2.07B | 2.11B | 2.07B | 2.01B | 1.95B | 1.85B | 1.72B | 457.2M | |
| Common Stock Shares Issued | 2.07B | 2.11B | 2.07B | 2.01B | 1.95B | 1.85B | 1.72B | 457.2M | |
| Common Stock Shares Authorized | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 2.70B | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 2.08B | 2.09B | 2.09B | 2.10B | 2.09B | 2.08B | 2.04B | 2.03B | 2.01B | 1.98B | 1.96B | 1.95B | 1.90B | 1.88B | 1.86B | 1.76B | 1.74B | 1.72B | 1.70B | 1.11B | 453.5M | 445.8M | 441.0M | 437.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 2.12B | 2.13B | 2.12B | 2.15B | 2.15B | 2.08B | 2.11B | 2.08B | 2.01B | 1.98B | 1.97B | 1.96B | 1.90B | 1.96B | 1.86B | 1.76B | 1.74B | 1.72B | 1.70B | 1.11B | 453.6M | 445.8M | 441.4M | 475.2M |
| Earnings Per Share Diluted | $3.11 | $0.63 | $0.83 | $1.20 | $0.47 | $-0.32 | $0.10 | $0.18 | $-0.08 | $-0.61 | $-1.33 | $-3.04 | $-1.28 | $0.58 | $-0.06 | $-0.62 | $-1.02 | $-1.70 | $-0.68 | $-4.72 | $-2.26 | $-2.21 | $-2.01 | $1.84 |
| Earnings Per Share Basic | $3.18 | $0.65 | $0.85 | $1.24 | $0.49 | $-0.31 | $0.11 | $0.19 | $-0.08 | $-0.61 | $-1.32 | $-3.03 | $-1.28 | $0.61 | $-0.06 | $-0.62 | $-1.02 | $-1.70 | $-0.68 | $-4.72 | $-2.23 | $-2.21 | $-1.99 | $2.00 |
| Common Stock Shares Outstanding | 2.08B | 2.09B | 2.09B | 2.10B | 2.10B | 2.09B | 2.05B | 2.04B | 2.02B | 1.99B | 1.98B | 1.96B | 1.92B | 1.88B | 1.87B | 1.76B | 1.75B | 1.73B | 1.70B | 1.70B | 457.8M | |||
| Common Stock Shares Issued | 2.08B | 2.09B | 2.09B | 2.10B | 2.10B | 2.09B | 2.05B | 2.04B | 2.02B | 1.99B | 1.98B | 1.96B | 1.92B | 1.88B | 1.87B | 1.76B | 1.75B | 1.73B | 1.70B | 1.70B | 457.8M | |||
| Common Stock Shares Authorized | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 5.00B | 2.70B | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.88B | $1.85B | $1.98B | $1.84B | $1.20B | $861.0M | $4.63B | $125.0M | $97.0M |
| Stock Issued During Period Value Stock Options Exercised | $25.0M | $132.0M | $46.0M | $19.0M | $101.0M | $80.0M | $21.0M | $27.0M | $4.0M |
| Operations And Support Expense | $2.85B | $2.73B | $2.69B | $2.41B | $1.88B | $1.82B | $2.30B | $1.52B | $1.35B |
| Costs And Expenses | $46.45B | $41.18B | $36.17B | $33.71B | $21.29B | $16.00B | $21.60B | $13.47B | $12.01B |
| Other Noncash Income Expense | -$166.0M | -$187.0M | -$106.0M | -$2.0M | -$4.0M | -$2.0M | -$15.0M | -$60.0M | $16.0M |
| Interest Paid Net | $386.0M | $475.0M | $629.0M | $513.0M | $449.0M | $412.0M | $332.0M | $124.0M | $61.0M |
| Foreign Currency Transaction Gain Loss Unrealized | $120.0M | -$308.0M | -$138.0M | -$96.0M | -$38.0M | -$48.0M | -$16.0M | -$53.0M | $59.0M |
| Disposal Group Not Discontinued Operation Gain Loss On Disposal | $0.00 | $204.0M | $14.0M | $1.68B | $204.0M | $0.00 | $3.21B | $0.00 | |
| Insurance Reserve Noncurrent | $9.08B | $7.04B | $4.91B | $3.03B | $2.55B | $2.22B | $2.30B | $2.00B | |
| Insurance Reserve Current | $3.39B | $2.75B | $2.08B | $1.69B | $1.44B | $1.24B | $1.12B | $941.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $478.0M | $489.0M | $448.0M | $452.0M | $470.0M | $493.0M | $504.0M | $515.0M | $482.0M | $494.0M | $484.0M | $369.0M | $292.0M | $282.0M | $287.0M | $191.0M | $143.0M | $285.0M | $426.0M | $3.94B | $10.0M | $74.0M | $11.0M | $17.0M |
| Stock Issued During Period Value Stock Options Exercised | $8.0M | $7.0M | $8.0M | $25.0M | $73.0M | $18.0M | $9.0M | $10.0M | $5.0M | $5.0M | $5.0M | $6.0M | $17.0M | $40.0M | $35.0M | $6.0M | $8.0M | $14.0M | $0.00 | $1.0M | $4.0M | $11.0M | $0.00 | |
| Operations And Support Expense | $735.0M | $696.0M | $668.0M | $687.0M | $682.0M | $685.0M | $683.0M | $664.0M | $640.0M | $617.0M | $617.0M | $574.0M | $475.0M | $432.0M | $423.0M | $365.0M | $582.0M | $503.0M | $498.0M | $864.0M | $434.0M | $387.0M | $349.0M | $372.0M |
| Costs And Expenses | $12.35B | $11.20B | $10.31B | $10.13B | $9.90B | $9.96B | $8.90B | $8.90B | $9.09B | $8.84B | $8.79B | $7.34B | $5.42B | $5.12B | $4.43B | $3.93B | $3.52B | $4.51B | $4.92B | $8.65B | $4.13B | $3.71B | $3.51B | $3.06B |
| Other Noncash Income Expense | $27.0M | $29.0M | -$4.0M | -$5.0M | -$65.0M | -$10.0M | -$2.0M | -$3.0M | ||||||||||||||||
| Interest Paid Net | $174.0M | $142.0M | $157.0M | $135.0M | $84.0M | $91.0M | $42.0M | $16.0M | ||||||||||||||||
| Foreign Currency Transaction Gain Loss Unrealized | $51.0M | -$150.0M | -$83.0M | $15.0M | -$13.0M | -$7.0M | $4.0M | $12.0M | ||||||||||||||||
| Disposal Group Not Discontinued Operation Gain Loss On Disposal | $0.00 | $14.0M | $0.00 | $0.00 | $0.00 | $0.00 | $1.68B | $0.00 | -$27.0M | $154.0M | $0.00 | $0.00 | $0.00 | $7.0M | $40.0M | $3.16B | ||||||||
| Insurance Reserve Noncurrent | $8.61B | $8.18B | $7.60B | $6.62B | $5.73B | $5.35B | $4.34B | $3.93B | $3.41B | $3.04B | $2.87B | $2.71B | $2.58B | $2.27B | $2.22B | $2.11B | $2.16B | $2.42B | $2.27B | $2.22B | $2.14B | |||
| Insurance Reserve Current | $3.27B | $3.11B | $2.87B | $2.52B | $2.39B | $2.08B | $1.82B | $1.73B | $1.66B | $1.43B | $1.45B | $1.42B | $1.38B | $1.22B | $1.22B | $1.29B | $1.25B | $1.07B | $1.02B | $977.0M | $961.0M |
Most recent annual filing with the SEC: February 13, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.